Colistin: recent data on pharmacodynamics properties and clinical efficacy in critically ill patients.
about
Colistin in Pig Production: Chemistry, Mechanism of Antibacterial Action, Microbial Resistance Emergence, and One Health PerspectivesColistin for lung infection: an updateNebulized antibiotics for ventilator-associated pneumonia: a systematic review and meta-analysisAntibiotic therapy of pneumonia in the obese patient: dosing and deliveryConvulsions in a critically ill patient on hemodialysis: Possible role of low dose colistinPolymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes.Tracking colistin-treated patients to monitor the incidence and outcome of carbapenem-resistant Gram-negative infections.Development and validation of an in vitro pharmacokinetic/pharmacodynamic model to test the antibacterial efficacy of antibiotic polymer conjugates.In vitro Activity of Colistin in Combination with Tigecycline against Carbapenem-Resistant Acinetobacter baumannii Strains Isolated from Patients with Ventilator-Associated Pneumonia.Host-dependent Induction of Transient Antibiotic Resistance: A Prelude to Treatment Failure.Impact of empirical antimicrobial therapy on the outcome of critically ill patients with Acinetobacter bacteremia.Pharmacodynamic evaluation of the intracellular activity of antibiotics towards Pseudomonas aeruginosa PAO1 in a model of THP-1 human monocytes.Colistin: an update on the antibiotic of the 21st century.Colistimethate sodium dry powder for inhalation: a review of its use in the treatment of chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.A review on colistin nephrotoxicity.Strategies to reduce curative antibiotic therapy in intensive care units (adult and paediatric).Antimicrobial Resistance in the Intensive Care Unit: A Focus on Gram-Negative Bacterial Infections.Successful use of extracorporeal membrane oxygenation in a human immunodeficiency virus infected patient with severe acute respiratory distress syndrome.Low-dose polymyxin: an option for therapy of Gram-negative sepsis.Invitro Activities of Polymyxins and Rifampicin against Carbapenem Resistant Acinetobacter baumannii at a Tertiary Care Hospital from South India.Characterization and Testing the Efficiency of Acinetobacter baumannii Phage vB-GEC_Ab-M-G7 as an Antibacterial Agent.A high-dose aminoglycoside regimen combined with renal replacement therapy for the treatment of MDR pathogens: a proof-of-concept study.Unveiling the Synergistic Interaction Between Liposomal Amphotericin B and Colistin.High-dose tigecycline and colistin for successful treatment of disseminated carbapenem-resistant Klebsiella pneumoniae infection in a liver transplant recipient.Intra-Pleural Colistin Methanesulfonate Therapy for Pleural Infection caused by Carbapenem-Resistant Acinetobacter Baumannii: A Successful Case Report.Risk factors for the first episode of Klebsiella pneumoniae resistant to carbapenems infection in critically ill patients: a prospective study.An usual approach to treatment of a case of multidrug resistance Pseudomonas aeruginosa peritonitis: parenteral and intraperitoneal aminoglycosides and parenteral colistin.Repurposing Zidovudine in combination with Tigecycline for treating carbapenem-resistant Enterobacteriaceae infections.Colistin-mediated neurotoxicity.Nephrotoxicity of High and Conventional Dosing Regimens of Colistin: A Randomized Clinical Trial.Colistin MIC variability by method for contemporary clinical isolates of multidrug-resistant Gram-negative bacilliSuccessful management of nosocomial ventriculitis and meningitis caused by extensively drug-resistant Acinetobacter baumannii in Austria.Evaluation of risk of nephrotoxicity with high dose, extended-interval colistin administration.Antibacterial activity of ceftolozane/tazobactam alone and in combination with other antimicrobial agents against MDR Pseudomonas aeruginosa.Intraventricular colistin in Gram-negative ventriculoperitoneal shunt infection in two pediatric patients.Antibiotic Dosing in Sustained Low-Efficiency Dialysis in Critically Ill PatientsRapid, simple, and clinically applicable high-performance liquid chromatography method for clinical determination of plasma colistin concentrations
P2860
Q28076261-39E55554-EBF0-4630-87BE-3075D12674C2Q28082041-47BE75E3-74B6-4CF6-BA8C-B018EA7A80C7Q28084615-DEB21E90-D022-4C74-9755-E794981F2BCDQ29248400-1F1A7097-2B8A-4B6B-BECA-3D0F3DF5F236Q34124176-2D8E3C3C-A09A-4C38-86CF-B702BEC537FDQ34552966-774510C9-3DC5-4F6E-9DC4-E2CD041D7080Q34974577-41E36A9B-B063-4503-AA3C-9C5D7DE8236DQ35169065-58370F76-272E-4DD2-937A-0FDA9B851A08Q36064268-AFBB92AC-BFD7-4FA3-803C-ED2F2D37B6F7Q36106267-256B8627-F66F-407C-90B3-3799ACAC4D2FQ36298237-2591D8E3-6F45-43AE-81B1-D3BB7772B025Q36785824-F73B46DF-D0C8-41F7-892B-C2D6A1244189Q38048852-D56C38E0-C61F-4ABF-991C-09A041431A46Q38186636-3C619DC4-1185-45BF-A9E5-749B335D27ACQ38501685-399E9E77-C413-4739-A41D-E77302D573D5Q38528292-8E5BEF8A-01DE-4F67-8B7A-DC79E9D91E5BQ38697988-47C5B79A-7E82-4CFC-A58B-857A62871D6CQ40223593-717632D4-A3D9-42E8-8749-5F58C417C673Q40272427-3A38601E-9EE8-4AE5-A30A-4D7171527D29Q40478475-68B007F3-B32D-408F-A652-4DBE33EBB78FQ40499136-6F221D96-0C74-4430-A99E-020A5148C22BQ40809870-D1F3D1C0-9A55-430F-9D56-591ECE03E8AEQ41071187-8D07FAB9-CAEC-4E89-97D2-9639A5A8E4F3Q41672820-AFC84264-F0F8-4BE3-8A39-A63357CC97BFQ41718733-A7396D7C-8E20-4C0F-B866-C48285FA104EQ41846236-642AB340-E417-4502-92F8-4876A1063795Q41873181-D0FC8399-4E1F-4BF3-853C-596690679C47Q41919457-D0642E8A-EB85-4DA9-96FA-67483E8D6677Q41953981-96620A41-6AC8-4269-929C-B2217C65B37FQ41990979-62CB63EF-4F96-4535-AFD1-C9F576CCA555Q42190018-5F24CE1D-05D5-4622-9764-8DA18653E8F1Q42233003-EFC9BCFC-E3A4-4D19-9319-BCE72B7B3834Q42762545-40860404-2480-47F3-B647-4A8F7A6386CBQ49616791-3D132359-1499-475B-9B03-92265E3E7D19Q54762674-F6D2B00E-96FA-44F7-B38B-BDE722F9971FQ57169898-D38C31C0-3C46-414F-A68B-C7CEBAC87449Q58765783-DE8A4B9C-2E75-441A-B919-BF910C139381
P2860
Colistin: recent data on pharmacodynamics properties and clinical efficacy in critically ill patients.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Colistin: recent data on pharm ...... cy in critically ill patients.
@ast
Colistin: recent data on pharm ...... cy in critically ill patients.
@en
Colistin: recent data on pharm ...... cy in critically ill patients.
@nl
type
label
Colistin: recent data on pharm ...... cy in critically ill patients.
@ast
Colistin: recent data on pharm ...... cy in critically ill patients.
@en
Colistin: recent data on pharm ...... cy in critically ill patients.
@nl
prefLabel
Colistin: recent data on pharm ...... cy in critically ill patients.
@ast
Colistin: recent data on pharm ...... cy in critically ill patients.
@en
Colistin: recent data on pharm ...... cy in critically ill patients.
@nl
P2860
P356
P1476
Colistin: recent data on pharm ...... cy in critically ill patients.
@en
P2093
Argyris S Michalopoulos
P2860
P2888
P356
10.1186/2110-5820-1-30
P577
2011-08-02T00:00:00Z
P5875
P6179
1002654388